You are here

Medical - global

Primary tabs

The medical working group is focused on issues that affect delivery of medical care to those in need

The medical working group seeks to address issues affecting delivery of medical care to those in need.

Members

Dr Ojia Adamolekun LadyCath mike kraft

Email address for group

medical-global@m.resiliencesystem.org

No consistent link found between antiviral drugs like Paxlovid and COVID rebound --U.S.G. reviews

 

Two systematic reviews by US federal agencies on the possible link between antiviral treatment for COVID-19 and viral rebound—one specifically on Paxlovid—find no consistent association. The studies were published yesteray in Morbidity and Mortality Weekly Report.

...

 

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Explainer: Understanding the labeling of the many COVID varients

 

...

A virus like this one has a lot of different names because it is changing constantly, and scientists need a common language to talk about a specific version that they’re seeing in a particular community or that they’re working with to develop treatments, vaccines and tests.

...

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

JN.1 designated by WHO as separate COVID-19 variant of interest

Due to its rapid growth and potential to add to the respiratory virus burden in Northern Hemisphere countries, the World Health Organization (WHO) today designated JN.1, part of the BA.2.86 SARS-CoV-2 lineage, as its own variant of interest.

Over the past month, the proportion of JN.1 viruses has rapidly increased, rising from 3.3% in early November to 27.1% by early December. Countries reporting the highest proportions include France, the United States, Singapore, Canada, and the United Kingdom.

Problem, Solution, SitRep, or ?: 

Information about about the JN.1 Variant of the COVID-19 Virus

What to Know About the JN.1 Variant of SARS-CoV-2 | Time

...

The fact that JN.1 is responsible for a growing portion of infections suggests it is either more contagious or better at getting past our bodies’ immune defenses than previous iterations of the virus, the CDC says. But there is no evidence that it causes more severe disease. The World Health Organization (WHO) has not labeled JN.1 a variant of concern—that is, a new strain of the SARS-CoV-2 virus with potential for increased severity; decreased vaccine effectiveness; or substantial impacts on health care delivery.

...

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Long COVID worse for patients than 'long flu' --study

 

In the 18 months after a serious COVID-19 or seasonal influenza infection, patients are at a significant increased risk of death, hospital readmission, or health problems affecting a number of organs, though COVID patients are hit harder, according to a study published ...in The Lancet Infectious Diseases.

...

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

howdy folks
Page loaded in 2.057 seconds.